Skip to content

Viking Therapeutics, Inc.

VKTX Nasdaq SEC CIK 1607678

Follow Viking Therapeutics Weekly email: filings, results, news

News

11 stories filed under Viking Therapeutics, grouped into ongoing threads

Data

Thread · 4 stories

Viking Therapeutics: 'Strong Buy' On Injectable VK2735 Maintenance Data And Treatment Optionality

Markets 1 d ago also on VIK

Viking Therapeutics stock surges 27% on weight loss drug data

Markets 1 d ago 3 sources also on VIK

Viking Therapeutics, Inc. (VKTX) Discusses Top Line Data from VK2735 Maintenance Study in Obesity and Type 2 Diabetes Transcript

Markets 1 d ago also on VIK

Viking Therapeutics Skyrockets On Obesity Drug Data. Eli Lilly, Novo Fall.

Markets 2 d ago 2 sources also on VIK LLY

More coverage

Viking Therapeutics stock falls on proposed equity offering

Markets 11 h ago 2 sources also on VIK

Viking Therapeutics plans $400 million capital raise

Markets 1 d ago also on VIK

Viking's Obesity Edge May Be Staying Power, Not Weight Loss

Markets 1 d ago also on VIK

VKTX Stock Soars as Viking Therapeutics Announces Positive GLP-1 Trial Results

Markets 2 d ago also on VIK GLP

3 Wall Street Analysts Think Viking Therapeutics Stock Will Roughly Triple Over the Next 12 Months. Here's Why I Think They're Wrong

Markets 21 d ago also on VIK

Viking Therapeutics: Mysterious GLP-1 Player With A Key Catalyst Due Q3 (Q2 Earnings Overview)

Earnings 48 d ago also on VIK GLP

Viking Therapeutics Declined in July, and why its Long-Term Prospects are Undiminished

Markets 49 d ago also on VIK

Next results

OCT28

Q1 2026 results

Wednesday · estimated from the filing cadence

Profile

Headquarters: SAN DIEGO, CA, United States
Sector: Healthcare
Industry: Pharmaceutical Preparations

Peers

Where this page comes from

Profile · SEC EDGAR

Next results · estimated from the filing cadence (SEC EDGAR)

News · 11 stories clustered from the RSS aggregator